Evidence map›Paper›PMID 32739464›Full record

SynthesisInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2020

Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis.

Bing-Bing Wu, Dong-Zhou Gu, Jia-Ning Yu, Jie Yang, Wang-Qin Shen

Registry-linked trialOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05859958 (ABO Blood Group Type Association With COVID-19 Severity - A Single Center Study), which is not on this map. Cited by 114 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 7 pooled it
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05859958 completednot on this mapstarted 2022, after this paper: background citation

ABO Blood Group Type Association With COVID-19 Severity - A Single Center Study

TypeobservationalSponsorArrowhead Regional Medical CenterRan2022 to 2023Enrolled599ConditionsCOVID-19, Blood Group Antigen Abnormality, Blood Group Incompatibilities, Diabetes MellitusArmsNo Intervention
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 7 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2021
    Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bing-Bing WuSchool of Medicine, Nantong University, Nantong, Jiangsu, PR China.
Dong-Zhou GuSchool of Medicine, Nantong University, Nantong, Jiangsu, PR China.
Jia-Ning YuSchool of Medicine, Nantong University, Nantong, Jiangsu, PR China.
Jie YangSchool of Medicine, Nantong University, Nantong, Jiangsu, PR China.
Wang-Qin ShenSchool of Medicine, Nantong University, Nantong, Jiangsu, PR China. Electronic address: 1819011117@stmail.ntu.edu.cn.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsThe COVID-19 spreads rapidly around the world which has brought a global health crisis. The pathogen of COVID-19 is SARS-COV-2, and previous studies have proposed the relationship between ABO blood group and coronavirus. Here, we aim to delve into the association between ABO blood group and COVID-19 infection, severity and demise.

methodsThe relevant studies were retrieved from five databases: PubMed, MedRxiv, BioRxiv,Web of Science and CNKI. Members of cases(symptomatic cases, severe cases, died cases) and controls(asymptomatic controls, non-severe controls, alive controls) were extracted from collected studies. Odds ratios (OR) and 95% confidence intervals (CI) were calculated and interpreted from extracted data. Publication bias and sensitivity analysis were also applied to confirm our discovery.

resultsOverall 31,100 samples were included in the analysis. Compared to other ABO blood type, an increased odds of infecting COVID-19 among individuals with A blood group (OR: 1.249, 95%CI: 1.114-1.440, P < 0.001) and a decreased odds of infecting COVID-19 among individuals with blood group O (OR: 0.699, 95%CI: 0.635-0.770, P < 0.001) were found. Besides, individuals with blood group AB seems to link a higher risk to COVID-19 severity (OR: 2.424, 95%CI: 0.934-6.294) and demise (OR: 1.348, 95%CI: 0.507-3.583). Meantime, individuals with O blood group might had lower risk to COVID-19 severity (OR: 0.748, 95%CI: 0.556-1.007), and individuals with B blood group were likely to relate a lower risk to COVID-19 demise.

conclusionsThe current meta-analysis suggest that blood type A might be more susceptible to infect COVID-19 while blood type O might be less susceptible to infect COVID-19; there were no correlation between ABO blood group and severity or demise of COVID-19. However, more investigation and research are warranted to clarify the relationship between COVID-19 and ABO blood type.

Indexed as

ABO Blood-Group SystemAdolescentAdultAgedBetacoronavirusCoronavirus InfectionsCOVID-19Disease SusceptibilityFemaleHumansMaleMiddle AgedOdds RatioPandemicsPneumonia, ViralRetrospective StudiesABO Blood-Group SystemABO blood group systemCOVID-19Meta-analysisMortalitySusceptibilitySystematic review

Identifiers

PMID32739464
PMCPMC7391292
OpenAlexW3046214948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.